Literature DB >> 10089303

Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.

J Liang1, J Choi, J Clardy.   

Abstract

The structure of the FKBP12-rapamycin-FRB ternary complex has now been refined at 2.2 A resolution. The cell-cycle arrest agent rapamycin binds FK506-binding protein (FKBP12) and the FKBP12-rapamycin binding (FRB) domain of FKBP12-rapamycin associated protein (FRAP) simultaneously, and the inhibition of FRAP is responsible for rapamycin's biological activity. The conformation of rapamycin in the ternary complex is very similar to that observed in the FKBP12-rapamycin binary complex, with an r.m.s. difference of only 0.30 A. However, a slight (9 degrees ) rotation repositions the FRB-binding face of rapamycin in the ternary complex. There are extensive rapamycin-protein interactions and relatively few interactions between the two protein partners FKBP12 and FRB, these interactions mainly involving residues in the 40s and 80s loops of FKBP12 and alpha1 and alpha4 of FRB. The high-resolution refinement has revealed the crucial role of several buried waters in the formation of the ternary complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089303     DOI: 10.1107/s0907444998014747

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  39 in total

1.  Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom.

Authors:  Cecelia A Shertz; Robert J Bastidas; Wenjun Li; Joseph Heitman; Maria E Cardenas
Journal:  BMC Genomics       Date:  2010-09-23       Impact factor: 3.969

2.  Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.

Authors:  Jean Christopher Chamcheu; Vaqar M Adhami; Stephane Esnault; Mario Sechi; Imtiaz A Siddiqui; Kenneth A Satyshur; Deeba N Syed; Shah-Jahan M Dodwad; Maria-Ines Chaves-Rodriquez; B Jack Longley; Gary S Wood; Hasan Mukhtar
Journal:  Antioxid Redox Signal       Date:  2016-10-04       Impact factor: 8.401

3.  A screen to identify small molecule inhibitors of protein-protein interactions in mycobacteria.

Authors:  Deborah Mai; Jennifer Jones; John W Rodgers; John L Hartman; Olaf Kutsch; Adrie J C Steyn
Journal:  Assay Drug Dev Technol       Date:  2011-01-31       Impact factor: 1.738

4.  Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling.

Authors:  Bruno D Fonseca; Graham H Diering; Michael A Bidinosti; Kush Dalal; Tommy Alain; Aruna D Balgi; Roberto Forestieri; Matt Nodwell; Charles V Rajadurai; Cynthia Gunaratnam; Andrew R Tee; Franck Duong; Raymond J Andersen; John Orlowski; Masayuki Numata; Nahum Sonenberg; Michel Roberge
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

5.  Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.

Authors:  Lalit Batra; Pradeep Shrestha; Hong Zhao; Kyle B Woodward; Alper Togay; Min Tan; Orlando Grimany-Nuno; Mohammad Tariq Malik; María M Coronel; Andrés J García; Haval Shirwan; Esma S Yolcu
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.422

Review 6.  Rapamycin passes the torch: a new generation of mTOR inhibitors.

Authors:  Don Benjamin; Marco Colombi; Christoph Moroni; Michael N Hall
Journal:  Nat Rev Drug Discov       Date:  2011-10-31       Impact factor: 84.694

7.  Light regulation of protein dimerization and kinase activity in living cells using photocaged rapamycin and engineered FKBP.

Authors:  Andrei V Karginov; Yan Zou; David Shirvanyants; Pradeep Kota; Nikolay V Dokholyan; Douglas D Young; Klaus M Hahn; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2010-12-16       Impact factor: 15.419

Review 8.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

9.  Large FK506-binding proteins shape the pharmacology of rapamycin.

Authors:  Andreas M März; Anne-Katrin Fabian; Christian Kozany; Andreas Bracher; Felix Hausch
Journal:  Mol Cell Biol       Date:  2013-01-28       Impact factor: 4.272

10.  Regulation of Cre recombinase by ligand-induced complementation of inactive fragments.

Authors:  Nicolas Jullien; François Sampieri; Alain Enjalbert; Jean-Paul Herman
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.